We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$180B
AUM Growth
+$20.4B
Cap. Flow
+$6.1B
Cap. Flow %
3.39%
Top 10 Hldgs %
26.13%
Holding
7,254
New
260
Increased
3,541
Reduced
2,314
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 8.85%
2 Healthcare 5.77%
3 Financials 5.26%
4 Consumer Discretionary 4.71%
5 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGS icon
5326
Transportadora de Gas del Sur
TGS
$4.79B
$112K ﹤0.01%
15,653
-583
-4% -$4.05K
ICPT
5327
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$112K ﹤0.01%
900
+100
+13% +$8.95K
ASPS icon
5328
Altisource Portfolio Solutions
ASPS
$63.6M
$111K ﹤0.01%
722
+291
+68% +$44.6K
AVXL icon
5329
Anavex Life Sciences
AVXL
$255M
$111K ﹤0.01%
42,939
+21,777
+103% +$57.2K
IOVA icon
5330
PUT
Iovance Biotherapeutics
IOVA
$1.82B
$111K ﹤0.01%
+4,000
New +$91K
MRNS
5331
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$111K ﹤0.01%
12,867
-1,891
-13% -$10.6K
PTR
5332
PUT
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$111K ﹤0.01%
2,200
-1,800
-45% -$88.6K
BPYU
5333
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$111K ﹤0.01%
6,025
-31,513
-84% -$597K
UFS
5334
PUT
DELISTED
DOMTAR CORPORATION (New)
UFS
$111K ﹤0.01%
2,900
+1,400
+93% +$51.8K
GNE icon
5335
Genie Energy
GNE
$367M
$110K ﹤0.01%
14,235
+6,169
+76% +$48.3K
IAG icon
5336
CALL
IAMGOLD
IAG
$8.2B
$110K ﹤0.01%
29,500
+4,600
+18% +$16.3K
PSEC icon
5337
CALL
Prospect Capital
PSEC
$1.07B
$110K ﹤0.01%
17,100
-6,200
-27% -$40.4K
QLD icon
5338
PUT
ProShares Ultra QQQ
QLD
$12.7B
$110K ﹤0.01%
7,200
-7,200
-50% -$97.5K
PAMT
5339
PAMT Corp
PAMT
$338M
$110K ﹤0.01%
7,652
+3,776
+97% +$55K
ACNT icon
5340
Ascent Industries
ACNT
$140M
$109K ﹤0.01%
8,497
+809
+11% +$11.2K
FTK icon
5341
Flotek Industries
FTK
$852M
$109K ﹤0.01%
9,133
+4,588
+101% +$52.9K
IJH icon
5342
iShares Core S&P Mid-Cap ETF
IJH
$122B
$109K ﹤0.01%
2,650
NVGS icon
5343
Navigator Holdings
NVGS
$1.38B
$109K ﹤0.01%
8,115
+3,197
+65% +$37.8K
SAMG icon
5344
Silvercrest Asset Management
SAMG
$79M
$109K ﹤0.01%
8,652
+4,383
+103% +$55.3K
SPRO icon
5345
Spero Therapeutics
SPRO
$67.7M
$109K ﹤0.01%
11,361
+5,853
+106% +$63.1K
QVCGA
5346
PUT
DELISTED
QVC Group Inc Series A
QVCGA
$109K ﹤0.01%
266
-10
-4% -$4.5K
VIA
5347
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$109K ﹤0.01%
2,375
+908
+62% +$45.4K
GOGO icon
5348
CALL
Gogo Inc
GOGO
$565M
$108K ﹤0.01%
16,800
-3,200
-16% -$18.6K
IQV icon
5349
PUT
IQVIA
IQV
$38.7B
$108K ﹤0.01%
700
-5,100
-88% -$745K
CENX icon
5350
CALL
Century Aluminum
CENX
$4.43B
$107K ﹤0.01%
14,300
-31,100
-69% -$215K

Similar funds

Barclays's Q4 2019 Portfolio in Review

As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.

  • Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
  • Barclays added most to Apple in Q4 2019, an estimated $572M increase.
  • Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
  • Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
  • Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
  • Barclays opened 260 new positions and closed 700 in Q4 2019.
  • Barclays's portfolio value rose 13% quarter-over-quarter to $180B.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.